Abstract:
The present invention relates to novel blue emitting Ce.sup.3+ activated borate phosphors which are used in fluorescent having lamps and TV tubes, having the formula A.sub.6 M.sub.1-x Ce.sub.x M'(BO.sub.3).sub.6 wherein A=La,Sr; M=La,Y, Gd, Lu; and M=Mg, Al, Ga, and x ranging from 0.001-1, and a process for the synthesis of the said activated borate phosphors.
Abstract:
The present invention relates to novel green emitting Tb.sup.3+ activated borate phosphors having the formula A.sub.6 M.sub.1-x Tb.sub.x M'(BO.sub.3).sub.6 wherein A=Sr; M=Y, Gd; M'=Sc, Y, Gd, Al, Ga; and 0.02.ltoreq.x.ltoreq.1, and a process for the synthesis of such activated borate phosphors.
Abstract:
The present invention relates to quick dissolve pharmaceutical compositions. More particularly the invention relates to quick dissolve pharmaceutical compositions of memantine hydrochloride capable of dissolving in the oral cavity and process for preparing such compositions. The quick dissolve pharmaceutical compositions of memantine hydrochloride contain at least one water-soluble diluent in particular a mono- or disaccharide and at least one disintegrant and optionally other pharmaceutically acceptable excipients.
Abstract:
The present invention relates to a monocompartment osmotic controlled drug delivery system comprising a poorly soluble drug and at least one alginic acid derivative.